PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.40%
Net income growth similar to META's 10.17%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
0.44%
Less D&A growth vs. META's 11.33%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-71.20%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.35%
SBC growth well above META's 16.57%. Michael Burry would flag major dilution risk vs. competitor’s approach.
236.20%
Slight usage while META is negative at -271.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
38.94%
AR growth while META is negative at -147.72%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
699.23%
Inventory growth of 699.23% while META is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-263.02%
Negative yoy AP while META is 144.49%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
147.57%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-405.17%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
69.40%
Operating cash flow growth above 1.5x META's 6.39%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-33.64%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1057.89%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-66.08%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
23.56%
Below 50% of META's 198.35%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
-1101.97%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.